Abstract

BackgroundMetabolic syndrome (MS) is prevalent in chronic kidney disease (CKD). Klotho, a protein linked to aging, is closely associated with CKD. Each component of MS and klotho has an association. However, little is known about the association between klotho and MS per se. We investigated the association between serum klotho levels and MS using baseline cross-sectional data obtained from a large Korean CKD cohort.MethodsOf the 2238 subjects recruited in the KoreaN Cohort Study for Outcome in Patients With Chronic Kidney Disease (KNOW-CKD) between 2011 and 2016, 484 patients with missing data on serum klotho and extreme klotho values (values lower than the detectable range or > 6000 pg/mL) or with autosomal dominant polycystic kidney disease patients were excluded. The data of the remaining 1754 subjects were included in the present study. MS was defined using the revised National Cholesterol Education Program Adult Treatment Panel (NCEP-ATP) III criteria. Serum klotho levels were measured using an enzyme-linked immunosorbent assay.ResultsMean patient age was 54.9 ± 12.1 years and 1110 (63.3%) were male. The prevalence of MS among all study subjects was 63.7% (n = 1118). The median serum klotho level was 527 pg/mL (interquartile range [IQR]: 418–656 pg/mL). Serum klotho level was significantly lower in MS patients than patients without MS (Median [IQR]; 521 pg/mL [413, 651] vs. 541 pg/mL [427, 676], respectively; P = 0.012). After adjusting for age, sex, estimated glomerular filtration rate, and overt proteinuria, serum klotho was independently associated with MS (adjusted odds ratio [OR], 0.44; 95% confidence interval, 0.23–0.82; P = 0.010). Furthermore, the adjusted OR for MS was found to be significantly increased at serum klotho levels of < 518 pg/mL (receiver operating characteristic curve cut-off value).ConclusionsSerum klotho was inversely associated with the presence of MS in patients with CKD.Trial registrationThis trial was registered on ClinicalTrials.gov on 26 June 2012 (https://clinicaltrials.gov;NCT01630486).

Highlights

  • Metabolic syndrome (MS) is prevalent in chronic kidney disease (CKD)

  • We investigated the metabolic profile characteristics of Korean CKD patients and evaluated the association between serum klotho and MS using baseline cross-sectional data obtained from a large Korean CKD cohort

  • Of 2238 CKD patients recruited between June 2011 and January 2016, 484 were excluded for the following reasons: 125 for missing serum klotho data; 9 for a serum klotho level lower than the detectable range; 3 for an extremely higher klotho level (> 6000 pg/ mL); and 347 for autosomal dominant polycystic kidney disease patients because large cystic masses in their kidneys and liver can cause an overestimation of abdominal obesity

Read more

Summary

Introduction

Metabolic syndrome (MS) is prevalent in chronic kidney disease (CKD). Klotho, a protein linked to aging, is closely associated with CKD. We investigated the association between serum klotho levels and MS using baseline cross-sectional data obtained from a large Korean CKD cohort. Genetic variants of Klotho have been associated with insulin resistance and hypertriglyceridemia [12]. It was suggested in all of these studies that klotho be considered a candidate molecule in MS. Little is known about the association between klotho and MS per se in CKD patients. We investigated the metabolic profile characteristics of Korean CKD patients and evaluated the association between serum klotho and MS using baseline cross-sectional data obtained from a large Korean CKD cohort

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call